This information can prove indispensable for the rational design of peptides of therapeutic importance
Overview of GLP-1 Receptor Agonists The major GLP-1 receptor agonists available on the market currently are: Dulaglutide (Trulicity) Exenatide extended release (Bydureon BCise) Exenatide (Byetta) Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) What is Dulaglutide (Trulicity) and its mechanism of action Dulaglutide, sold as Trulicity, is an injectable GLP-1 receptor agonist medication designed for the treatment of type 2 diabetes
It also helps research buyers distinguish catalog information from scientific claims
Heres how each one helps: Glutathione reduces melanin production and brightens overall skin tone Tranexamic acid stops inflammation that causes dark spots and melasma (brown patches) Niacinamide improves skin texture, reduces redness, and strengthens the skin barrier Together, these three ingredients attack dark spots from different angles, giving you faster and better results
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH) developed by Novo Nordisk, displaying high GH-releasing potency and efficacy both in vitro and in vivo
Retatrutide represents a next generation approach for patients who want more comprehensive metabolic support